Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.

Erb SM, Butrapet S, Moss KJ, Luy BE, Childers T, Calvert AE, Silengo SJ, Roehrig JT, Huang CY, Blair CD.

Virology. 2010 Oct 25;406(2):328-35. doi: 10.1016/j.virol.2010.07.024. Epub 2010 Aug 13.

PMID:
20708768
[PubMed - indexed for MEDLINE]
Free Article
2.

Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.

Butrapet S, Childers T, Moss KJ, Erb SM, Luy BE, Calvert AE, Blair CD, Roehrig JT, Huang CY.

Virology. 2011 Apr 25;413(1):118-27. doi: 10.1016/j.virol.2011.01.030. Epub 2011 Feb 24.

PMID:
21353281
[PubMed - indexed for MEDLINE]
Free Article
3.

Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes.

Bryant JE, Calvert AE, Mesesan K, Crabtree MB, Volpe KE, Silengo S, Kinney RM, Huang CY, Miller BR, Roehrig JT.

Virology. 2007 Sep 30;366(2):415-23. Epub 2007 Jun 1.

PMID:
17543367
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion.

Huang CY, Butrapet S, Moss KJ, Childers T, Erb SM, Calvert AE, Silengo SJ, Kinney RM, Blair CD, Roehrig JT.

Virology. 2010 Jan 20;396(2):305-15. doi: 10.1016/j.virol.2009.10.027. Epub 2009 Nov 12.

PMID:
19913272
[PubMed - indexed for MEDLINE]
Free Article
6.

Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.

Abd-Jamil J, Cheah CY, AbuBakar S.

Protein Eng Des Sel. 2008 Oct;21(10):605-11. doi: 10.1093/protein/gzn041. Epub 2008 Jul 30.

PMID:
18669522
[PubMed - indexed for MEDLINE]
Free Article
7.

Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.

Mondotte JA, Lozach PY, Amara A, Gamarnik AV.

J Virol. 2007 Jul;81(13):7136-48. Epub 2007 Apr 25.

PMID:
17459925
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

E/NS1 modifications of dengue 2 virus after serial passages in mammalian and/or mosquito cells.

Chen WJ, Wu HR, Chiou SS.

Intervirology. 2003;46(5):289-95.

PMID:
14555849
[PubMed - indexed for MEDLINE]
9.

Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity.

Kroschewski H, Sagripanti JL, Davidson AD.

J Gen Virol. 2009 Oct;90(Pt 10):2457-61. doi: 10.1099/vir.0.011486-0. Epub 2009 Jul 8.

PMID:
19587132
[PubMed - indexed for MEDLINE]
Free Article
10.

Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.

Johnson BW, Chambers TV, Crabtree MB, Guirakhoo F, Monath TP, Miller BR.

Am J Trop Med Hyg. 2004 Jan;70(1):89-97.

PMID:
14971704
[PubMed - indexed for MEDLINE]
Free Article
12.

Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.

Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, Jairungsri A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N.

J Virol. 2004 Mar;78(5):2367-81.

PMID:
14963133
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Demonstration of binding of dengue virus envelope protein to target cells.

Chen Y, Maguire T, Marks RM.

J Virol. 1996 Dec;70(12):8765-72.

PMID:
8971005
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes.

Johnson BW, Chambers TV, Crabtree MB, Bhatt TR, Guirakhoo F, Monath TP, Miller BR.

Am J Trop Med Hyg. 2002 Sep;67(3):260-5.

PMID:
12408664
[PubMed - indexed for MEDLINE]
Free Article
17.

High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.

Jaiswal S, Khanna N, Swaminathan S.

Protein Expr Purif. 2004 Jan;33(1):80-91.

PMID:
14680965
[PubMed - indexed for MEDLINE]
18.

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.

Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM.

Nat Med. 1997 Aug;3(8):866-71.

PMID:
9256277
[PubMed - indexed for MEDLINE]
19.

Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML.

J Gen Virol. 2005 Feb;86(Pt 2):405-12.

PMID:
15659760
[PubMed - indexed for MEDLINE]
Free Article
20.

Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome.

Cahour A, Pletnev A, Vazielle-Falcoz M, Rosen L, Lai CJ.

Virology. 1995 Feb 20;207(1):68-76.

PMID:
7871753
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk